Tag: Anaphylactic Shock
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Algorithm enables immunization of most individuals, with 0.7 percent developing anaphylactic reaction after one BNT162b2 dose
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate second dose
$345 Million Settlement Proposed in EpiPen Lawsuits
Pfizer spokesperson denied any wrongdoing and said settlement was sought to avoid 'the distraction of continued litigation'
Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines
Janssen adenovirus type 26 vectored vaccine may be considered for individuals who self-report PEG allergy
ACAAI Updates Guidance for Allergic Reactions to COVID-19 Vaccines
Guidance relates to risks for allergic reactions for mRNA (Moderna and Pfizer) and adenovirus vector (Johnson & Johnson) COVID-19 vaccines
Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
Most recipients with anaphylaxis had allergy histories, with 31 percent having prior anaphylaxis
1998 to 2018 Saw Jump in Admissions for Food-Induced Anaphylaxis
U.K. data revealed decrease in case fatality rate during study period; cow's milk responsible for 26 percent of deaths in school-aged children
Prevalence of Peanut Allergy 2.9 Percent Among U.S. Adults
More than 17 percent of adults with peanut allergy reported onset in adulthood; about one in five had ED visits in past year
2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots
Nine of the 10 cases occurred in individuals with documented history of allergies, allergic reactions
Allergists Affirm Safety of COVID-19 Vaccines for Most
All patients should be observed for 15 minutes after vaccination; staff should be trained in anaphylaxis management
